<< Read Full Article
<< Read Full Article
Verdict Boosts Amgen
A jury voted in favor of Amgen(AMGN Quote) Tuesday in a patent dispute case, according to a Bloomberg report.
The ruling determines in effect that Roche may not sell Mircera, its rival medicine to Amgen's Aranesp and Epogen anemia drugs, in the U.S.
Amgen shares were rising 87 cents, or 1.6%, to $56.99 in recent trading....
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,350.73 | 1,101.57 | 2,196.65 | 35.08 |
Oil *
74.19
|
|
UP
42.47
|
UP
5.50
|
UP
16.60
|
UP
0.21
|
10 Yr
3.51%
SPDR Gold
107.34
|
|
+0.41%
|
+0.50%
|
+0.76%
|
+0.60%
|
Data delayed 20 minutes |
Connect with TheStreet